Ulla Impola

Author PubWeight™ 11.07^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Matrix metalloproteinase-19 expression in dermal wounds and by fibroblasts in culture.	J Invest Dermatol	2003	1.57
2	N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible.	Stem Cells	2006	1.43
3	Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage.	Glycoconj J	2008	1.05
4	Matrix metalloproteinase inhibitor BB-3103 unlike the serine proteinase inhibitor aprotinin abrogates epidermal healing of human skin wounds ex vivo.	J Invest Dermatol	2002	0.98
5	Identification of alpha-1 acid glycoprotein as a lysophospholipid binding protein: a complementary role to albumin in the scavenging of lysophosphatidylcholine.	Biochemistry	2006	0.97
6	Human CMP-N-acetylneuraminic acid hydroxylase is a novel stem cell marker linked to stem cell-specific mechanisms.	Stem Cells	2010	0.92
7	Ectopic localization of matrix metalloproteinase-9 in chronic cutaneous wounds.	Hum Pathol	2002	0.91
8	Matrilysin-2 (matrix metalloproteinase-26) is upregulated in keratinocytes during wound repair and early skin carcinogenesis.	J Invest Dermatol	2005	0.87
9	Matrix metalloproteinase-19 is expressed by keratinocytes in psoriasis.	Acta Derm Venereol	2003	0.83
10	Matrix metalloproteinase-21 is expressed epithelially during development and in cancer and is up-regulated by transforming growth factor-beta1 in keratinocytes.	Lab Invest	2003	0.81
11	Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas.	Mod Pathol	2006	0.78
12	Matrilysin-1 (MMP-7) and MMP-19 are expressed by Paget's cells in extramammary Paget's disease.	J Cutan Pathol	2004	0.75